BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Prognosis
21 results:

  • 1. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.
    Muñoz-Galván S; Verdugo-Sivianes EM; Santos-Pereira JM; Estevez-García P; Carnero A
    J Exp Clin Cancer Res; 2024 Feb; 43(1):57. PubMed ID: 38403587
    [TBL] [Abstract] [Full Text] [Related]  

  • 2.
    Chen B; Jiang K; Wang H; Miao L; Lin X; Chen Q; Jing L; Lu X
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):220. PubMed ID: 37796700
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CD109 Promotes Drug Resistance in A2780 ovarian cancer Cells by Regulating the STAT3-notch1 Signaling Axis.
    Kim JS; Shin MJ; Lee SY; Kim DK; Choi KU; Suh DS; Kim D; Kim JH
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373457
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppresses the stemness of ovarian cancer via notch1 pathway.
    Yang L; Yang M; Cui C; Long X; Li Y; Dai W; Lang T; Zhou Q
    Cell Signal; 2023 Jul; 107():110688. PubMed ID: 37105506
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer development.
    Chai H; Pan C; Zhang M; Huo H; Shan H; Wu J
    BMC Cancer; 2023 Jan; 23(1):96. PubMed ID: 36707804
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling pathway.
    Chen S; Cai K; Zheng D; Liu Y; Li L; He Z; Sun C; Yu C
    Cell Death Dis; 2022 Nov; 13(11):945. PubMed ID: 36351890
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing: A Korean Gynecologic Oncology Group study (KGOG 3047).
    Sa JK; Kim J; Kang S; Kim SW; Song T; Shim SH; Choi MC; No JH; Song JY; Kim D; Kim YM; Kim JH; Lee JW
    Int J Cancer; 2022 Oct; 151(7):1086-1097. PubMed ID: 35666535
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Loss of Krüppel-like factor 9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via notch1/slug signaling.
    Wang K; Liu S; Dou Z; Zhang S; Yang X
    Cancer Sci; 2021 Oct; 112(10):4220-4233. PubMed ID: 34363722
    [TBL] [Abstract] [Full Text] [Related]  

  • 9.
    Xu Z; Zhuang L; Wang X; Li Q; Sang Y; Xu J
    Future Oncol; 2020 Sep; 16(25):1921-1930. PubMed ID: 32915667
    [No Abstract]    [Full Text] [Related]  

  • 10. Hsa_circ_0009910: oncogenic circular RNA targets microRNA-145 in ovarian cancer cells.
    Li Y; Lin S; An N
    Cell Cycle; 2020 Aug; 19(15):1857-1868. PubMed ID: 32588730
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating notch1-c-Myc pathway.
    Zhu W; Niu J; He M; Zhang L; Lv X; Liu F; Jiang L; Zhang J; Yu Z; Zhao L; Bi J; Yan Y; Wei Q; Huo H; Fan Y; Chen Y; Ding J; Wei M
    J Transl Med; 2019 Aug; 17(1):259. PubMed ID: 31395064
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
    Zhao J; Liu HR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Expressions of OCT4, notch1 and DLL4 and their clinical implications in epithelial ovarian cancer].
    Yu L; Jiao YJ; Zhou L; Song WQ; Wu SW; Wang DN
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):444-450. PubMed ID: 28446394
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic roles of Notch receptor mRNA expression in human ovarian cancer.
    Chen C; Wang X; Huang S; Wang L; Han L; Yu S
    Oncotarget; 2017 May; 8(20):32731-32740. PubMed ID: 28415574
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Inhibition of gamma-secretase in notch1 signaling pathway as a novel treatment for ovarian cancer.
    Feng Z; Xu W; Zhang C; Liu M; Wen H
    Oncotarget; 2017 Jan; 8(5):8215-8225. PubMed ID: 28030808
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Distinct prognostic values of four-Notch-receptor mRNA expression in ovarian cancer.
    Zhou X; Teng L; Wang M
    Tumour Biol; 2016 May; 37(5):6979-85. PubMed ID: 26662955
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Increased notch1 expression is associated with poor overall survival in patients with ovarian cancer.
    Alniaimi AN; Demorest-Hayes K; Alexander VM; Seo S; Yang D; Rose S
    Int J Gynecol Cancer; 2015 Feb; 25(2):208-13. PubMed ID: 25611897
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Overexpression of goosecoid homeobox is associated with chemoresistance and poor prognosis in ovarian carcinoma.
    Kang KW; Lee MJ; Song JA; Jeong JY; Kim YK; Lee C; Kim TH; Kwak KB; Kim OJ; An HJ
    Oncol Rep; 2014 Jul; 32(1):189-98. PubMed ID: 24858567
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells.
    Mitsuhashi Y; Horiuchi A; Miyamoto T; Kashima H; Suzuki A; Shiozawa T
    Histopathology; 2012 Apr; 60(5):826-37. PubMed ID: 22348356
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. cancer stem cell and embryonic development-associated molecules contribute to prognostic significance in ovarian cancer.
    Oktem G; Sanci M; Bilir A; Yildirim Y; Kececi SD; Ayla S; Inan S
    Int J Gynecol Cancer; 2012 Jan; 22(1):23-9. PubMed ID: 22080880
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.